SCI Abstract

search
Mechanistic analysis on epigenetic programming of tumor drug resistance
All content on this site: Copyright © 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
Therapy-induced microenvironmental senescence in tumor treatment resistance: From mechanism to therapy
All content on this site: Copyright © 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
Resensitizing drug-resistant cancers by co-targeting apoptosis and mitochondrial stress pathway
All content on this site: Copyright © 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
Adaptive lineage plasticity drives multidrug resistance to KRAS-EGFR targeted therapy
All content on this site: Copyright © 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
MZF1-mediated GAPDH overexpression drives glycolytic reprogramming and neuroendocrine progression in advanced prostate cancer
All content on this site: Copyright © 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
Targeting a novel metabolic vulnerability of non-small cell lung cancer to fatty acid oxidation surmounts chemoresistance
All content on this site: Copyright © 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
ITPKB suppresses ER calcium release to promote CXCL9 expression and enhance immunotherapy sensitivity in triple-negative breast cancer
All content on this site: Copyright © 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
ZBED6-driven nucleotide metabolic reprogramming improves sensitivity to anti-PD1 therapy in NK/T cell lymphoma
All content on this site: Copyright © 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
OGT-mediated O-GlcNAcylation of BICD2 drives gemcitabine resistance in pancreatic cancer via accelerating G2/M cell cycle progression
All content on this site: Copyright © 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
Tumor-intrinsic PHGDH inhibition sensitizes colorectal cancer to PD-1 blockade via α-ketoglutarate–mediated macrophage reprogramming
All content on this site: Copyright © 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
Piperidine-derived resensitizers revive aminoglycoside capacity against persister cells of Pseudomonas aeruginosa in vivo
All content on this site: Copyright © 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
Resistance to CAR-based cell therapy: Mechanisms and overcoming strategies
All content on this site: Copyright © 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
Immunotherapy in cancer: Mechanisms and strategies to overcome resistance
All content on this site: Copyright © 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
Biomimetic delivery systems for overcoming drug resistance in gastrointestinal cancers
All content on this site: Copyright © 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
Consensus on standardized later-line systemic therapy for hepatocellular carcinoma
All content on this site: Copyright © 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
Extracellular matrix stiffness and mechanotransduction in cancer drug resistance
All content on this site: Copyright © 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
Metabolic basis of fatty acid oxidation and immunotherapy resistance with clinical perspectives
Volume 84, January 2026, 101317Author links open overlay panel, Section snippetsCRediT authorship contribution statementJu...
Three decades of ESKAPEE antimicrobial resistance: Emerging burdens in working-age individuals and high-income regions
Volume 84, January 2026, 101325Author links open overlay panel, , Section snippetsCRediT authorship contribution statement...
Glucocorticoid receptor activated by dexamethasone promotes the chemoresistance and stemness of lung cancer
Siyuan Chen: Writing – review & editing, Formal analysis. Huaicheng Tan: Methodology, Formal analysis, Data curation. ...
Lars2-signaling mediates platinum resistance by accumulating cancer stem cell population and suppressing anti-tumor immunity
Platinum-based chemotherapy remains a cornerstone of cancer treatment; however, its clinical efficacy is frequently compro...
Hyperbaric oxygen targets RCN1 to modulate ER-mitochondria crosstalk and ameliorate sorafenib resistance in hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is counted among the top four causes of cancer-associated deaths globally and exhibits a gr...
UBL3 governs VEGFR inhibitor resistance by activating NOTCH signaling in renal cell carcinoma
Volume 85, March 2026, 101332Author links open overlay panel, , , , , , , , , , , , , , , AbstractBackgroundTargeted thera...